Start personalised breast cancer prevention today

AnteBC

Take charge of your breast cancer risk with personalised prevention. Through advanced genetic analysis, we provide a tailored screening and prevention plan designed specifically for you. Even without a family history of cancer, genetic risk assessment can offer early insights to help you stay proactive about your health.

Discover your genetic risk level for breast cancer
Get personalised medical guidance on when to start screening and how often
Learn actionable steps to reduce your risk
Powered by clinical-grade genetic testing with a saliva collection kit delivered to your door
Access your clinical recommendations online within 6 weeks
Recommended for women aged 30 and above

Important information

E-mail *

Test results are connected to the e-mail you provide.

Product price:	£ 299.00
Additional options total:
Order total:

Changemakers

Routine breast screening starts at 50, but 1 in 5 cases affect younger women. Early prevention is crucial.

The current breast cancer reality

1 in 7

Breast cancer is the most common cancer in women, affecting 1 in 7 women in their lifetime.
1 in 5

Routine breast screening starts at the age of 50. Did you know that 1 in 5 breast cancer cases affect women under 50? Early prevention is crucial.
1 in 2

Currently, only 55% of breast cancer cases in the UK are caught early when survival rates can reach 99%. Let's change this together.

Next-generation prevention

Personalised breast cancer prevention with genetic risk assessment can give early warning to women at risk even if there is no cancer in the family. Moreover, it guides you towards tailored screening and prevention based on personal risk levels.

More than just genetic testing. Here's what you'll learn:

View sample report

What is my genetic risk level of breast cancer
At what age should you start breast cancer screening, and how often
Are there additional measures you can take to lower your risk
What proactive measures can you adopt to reduce your likelihood of developing breast cancer
What changes and symptoms should you monitor regarding breast cancer
What should your doctor know

Prevent breast cancer based on your unique risk profile

Breast cancer and related deaths can often be prevented through timely measures, even before symptoms develop.
Each woman’s risk of developing breast cancer is highly individual. For those at high genetic risk, the likelihood of developing breast cancer can already be significant in their 30s and 40s. This should be carefully considered when planning screenings.
Your prevention plan is fully personalised by considering your genetic makeup, age, sex, and ethnicity.

Health-conscious women aged 30 and above – Looking for science-backed prevention strategies.
Especially beneficial for women under 50 – To identify those at higher risk before NHS routine screening starts.
Those with or without a family history – Genetic risk can be significant even without familial cases that make up only 20% of current cases.

Many cancers result from a combination of multiple genetic factors, making them polygenic. Polygenic Risk Score (PRS) is a measure of disease risk based on analysis of multiple genetic variants associated with the disease. Polygenic risk can be significant even without a family history of cancer.
The Antegenes PRS technology calculates the combined effect of 2803 genetic variants associated with breast cancer, generating a risk score for developing the condition.
By combining the PRS with your background (ethnicity, age and sex), we provide accurate risk assessments and tailored medical advice to prevent illness or promote early detection.

Personalised breast cancer prevention includes:

Saliva-based genetic risk test for breast cancer;
Combined effect analysis of 2803 genetic variants associated with breast cancer across the genome;
Your polygenic risk score for breast cancer;
Breast cancer risk compared to the general female population in your country;
Probability of developing the condition within 10 years;
Interpretation of test results with clinical recommendations for prevention and screening with clear steps on what you should do next;
Hereditary cancer questionnaire to assess additional monogenic risk factors;
The test report includes additional comprehensive clinical guidelines for your local healthcare professionals, guiding the next possible medical steps for personalised breast cancer prevention.
With scientifically backed and well-documented medical advice, the information you receive may support access to further testing or follow-up care within your local healthcare system, whether public or private, helping you take proactive steps to protect your health.
If you have any questions regarding your results, the Breast Awareness Clinic offers optional post-test consultations and support for patients seeking personalised medical guidance.

Start today

How it works

1 Order your kit
Order your kit online by filling in the form below.
2 Provide a sample at home
Provide a sample using a simple saliva spit collection kit and use the prepaid envelope to return your sample.
3 Complete the questionnaire
Complete the family history questionnaire on our patient portal to assess additional monogenic risk factors for hereditary breast cancer.
4 Receive your results
You can access your results within 6 weeks online accompanied by medical recommendations that guide your next steps.

Optional post-test medical consultation

Understanding your breast cancer risk is an important step — and if you would like further guidance or support after receiving your results, you have the option to book a consultation with experienced specialists in breast health and genetics.

You can choose between two optional consultation pathways:

Senior Breast Clinical Nurse Specialist Laura Naylor
Laura has over 15 years of experience in breast cancer diagnosis and care. Her virtual consultations offer emotional and psychological support, practical advice on lifestyle and prevention, and education on breast awareness and self-examination.

For a more in-depth session, Laura also offers face-to-face appointments, including a clinical breast examination, personalised risk discussion, and hands-on guidance on how to perform breast self-checks.

Book a consultation with Laura
Consultant Geneticist Prof. Gareth Evans
An internationally recognised expert in cancer genetics, Professor Evans has led pioneering work in hereditary breast cancer. His consultation offers expert insight into your personal and family genetic risk, hereditary cancer screening options, and medical recommendations tailored to your genetic profile.

Book a consultation with Prof. Evans

Approved by doctors and women

What people say

I am one of those who became a breast cancer survivor under the age of 50. But at the same time, I am very lucky because I knew about my high polygenic risk score earlier thanks to the Antegenes genetic test and started having mammograms and ultrasounds several years ago. My cancer (a subtle lobular form that did not make itself felt at all) was discovered during a regular annual check-up as a small and easily treatable cancer. Only the PRS showed a high risk of breast cancer; a later genetic test during treatment did not find any common mutations associated with cancer. Without the Antegenes test, I might not have suspected that it would be wise for me to have a breast examination before the age of 50.

Kate, 48
"Since I am younger than the age of being called for breast cancer screening, it was important for me to take a genetic risk test to find out my own genetic risk assessment of breast cancer and what I can do at a younger age to maintain my health. I found out that I have a higher risk and I’m now advised to go for a mammography screening as early as age 40 and should do it every two years. This is why I strongly encourage and recommend this kind of genetic testing – it gave me a sense of peace."

Hanna, 32
I never would have thought that I might have an increased risk of breast cancer – especially since there has never been any cancer in my family. Personalised breast cancer prevention gave me a clear plan to follow, including starting mammography screenings from the age of 36. I’m also committed to following the lifestyle recommendations that came with the plan to reduce my risk through healthy habits. Now I know how to take care of myself and when to start with screenings. This knowledge is truly invaluable.

Anna, 33

We’re here to answer your questions

What does personalised breast cancer prevention include?
Personalised breast cancer prevention includes:
- Saliva-based genetic risk test for breast cancer;
- Combined effect analysis of 2803 genetic variants associated with breast cancer across the genome;
- Your polygenic risk score for breast cancer;
- Breast cancer risk compared to the general female population in your country;
- Probability of developing the condition within 10 years;
- Interpretation of test results with clinical recommendations for prevention and screening with clear steps on what you should do next;
- Hereditary cancer questionnaire to assess additional monogenic risk factors;
- The test report includes additional comprehensive clinical guidelines for your local healthcare professionals, guiding the next possible medical steps for personalised breast cancer prevention.
- With scientifically backed and well-documented medical advice, the information you receive may support access to further testing or follow-up care within your local healthcare system, whether public or private, helping you take proactive steps to protect your health.
- In case you have questions regarding your results, the Breast Awareness Clinic in Manchester provides optional post-test consultations and support for patients seeking personalised medical guidance.
AnteBC Test Limitations
- AnteBC test is not used to diagnose breast cancer.
- An elevated risk estimated by the AnteBC test does not mean that you will develop breast cancer during their lifetime. Also, a moderate or lower risk does not mean that the probability of developing the diseases is zero.
- AnteBC test does not assess the risk of your family and relatives, i.e. polygenic risk score-based disease risks may not be transmitted directly from parents to children.
- AnteBC test does not analyze rare pathogenic mutations in genes that significantly increase the risk of breast cancer, such as BRCA1, BRCA2, CHEK2, PALB2, ATM, TP53, CDH1, STK11, and others.
- The AnteBC test is based on the most up-to-date scientific data, which may, however, be supplemented and changed in the future as additional information becomes available. The field of genetics is constantly evolving, which may lead to changes in risk assessments over time, as well as changes in test selection recommendations and clinical recommendations based on test results.
- Different polygenic risk scores predicting risks of the same trait may give different estimates of the individual’s risks due to differences in the genetic variants included in the models and their weights.
- The results of this test should be applied in context with other relevant clinical data. In addition to the possible genetic predisposition, other risk factors also influence the risk of breast cancer.

Fully compliant with all regulatory bodies

Personalised cancer prevention is based on genetic risk tests provided by Antegenes.

✔ CE-marked medical devices (in vitro diagnostics, IVD)
✔ Registered in the UK MHRA Registry and EUDAMED database
✔ Developed using anonymised data from the UK Biobank
✔ Antegenes is ISO 13485 certified
✔ We take your data privacy and protection very seriously